In mouse models, combination treatment of OSI-906 (an IGF1R/IR inhibitor) and PF-4708671 (a p70S6K inhibitor) significantly reduces IGF1R/IR inhibitor-resistant colorectal tumor growth [93]. This evidence concerns the gene INSR and colorectal neoplasm.